AI-powered evaluation using the Model Context Optimization BS Detection Framework, based solely on publicly available website content.
Based on 784 businesses audited.
Medical Devices, Pharma & Biotech BS: ABILIFY (aripiprazole) / Otsuka America Pharmaceutical, Inc. (abilify.com)
This is a low-BS, high-substance clinical site where regulatory constraints have successfully purged standard marketing hyperbole. It provides exactly what it claims: forensic safety data and specific use-case indications for a regulated pharmaceutical product.
Implement pharmacological and Organization schema to bridge the technical authority gap. Repair the broken link on the savings program video page to ensure a seamless user journey. Include direct links to peer-reviewed clinical trial summaries on ClinicalTrials.gov to provide external verification for the listed indications. Consolidate repetitive safety blocks using expandable UI elements to improve readability while maintaining legal compliance.
Information density is exceptionally high due to the regulatory nature of the product. Headings like H1 What is ABILIFY for? and H3 Stay on schedule lead directly to dense body text containing specific psychiatric indications, age-specific treatment brackets (e.g., pediatric patients 6 to 17), and a granular list of side effects including technical terms like akathisia and tardive dyskinesia. Fluff power words are virtually non-existent, replaced by technical nouns and safety warnings.
If your @id chain is broken, your entire knowledge graph collapses into isolated nodes. Check your AI visible entity graph with a free one page structured data interpretation.
There is zero semantic drift across the analyzed pages. The homepage establishes a clinical tone focused on indications and safety, which is rigorously maintained through sub-pages like Taking ABILIFY and the Savings Program. The site’s promise to explain what the drug is for is substantiated by verbatim regulatory text and specific use-cases for MDD, Bipolar I, and Schizophrenia.
Stop the ROI leak caused by technical debt and strategic misalignment. Conduct an Independent Strategic Diagnosis for 1 Euro to identify high impact issues across all audit categories.
The site avoids trust theatre entirely. There are no unverified testimonials or generic trust badges; instead, it relies on institutional credibility, citing Otsuka America Pharmaceutical, Inc. and providing direct phone lines for the FDA (1-800-FDA-1088) and pharmacovigilance reporting. The review_count is 0 because the site correctly treats medicine as a clinical matter rather than a consumer-reviewed commodity.
Proof density is high but restricted to internal documents and regulatory bodies. The site frequently refers to the ‘U.S. FULL PRESCRIBING INFORMATION’ as the primary source of truth. While it lacks external peer-reviewed publication links in the crawled text, the level of specific contraindication and adverse event data provides more substance than 99% of commercial websites.
To see how the system reconstructs a medical entity graph at scale, review the full Cleveland Clinic Structured Data audit. View the Cleveland Clinic Structured Data Audit for a live example of identity level decomposition and cross page entity mapping.
The fingerprint is largely driven by industry-standard pharmaceutical templates, specifically the ‘boxed warning’ and ‘Important Safety Information’ blocks that appear on every page. While these are template-based, they are mandated substance rather than marketing fluff. The value proposition of brand-name ABILIFY and the $5 savings card is specific and cannot be copy-pasted onto a generic competitor without changing the legal and chemical specifics.
The primary authority gap is technical rather than content-driven. The lack of structured data (schema_json is null) and a broken link/404 page encountered on the savings program video sub-page represent a gap between the brand’s medical authority and its digital execution. However, the presence of specific corporate entity names and regulatory reporting paths provides high verifiable authority.
There is no disconnect between marketing tone and demonstrated proof. Performance claims are restricted to FDA-approved indications. The site does not claim to ‘cure’ or ‘transform’ in a vague marketing sense; it specifies ‘Treatment of manic or mixed episodes’ and ‘Use as an add-on treatment,’ which are medically defined performance parameters.
Medical Devices, Pharma & Biotech BS: ABILIFY (aripiprazole) / Otsuka America Pharmaceutical, Inc. (abilify.com)
The site is perfectly aligned with the Pharma & Biotech category. Every page is dominated by FDA-mandated safety disclosures, specific medical indications, and pharmacological information regarding aripiprazole.
Before embeddings, before entities, before retrieval — the crawler must reach the text. Open the Crawlability & Indexation Guide to learn how access failures erase meaning long before interpretation begins.
“The score is driven almost entirely by technical gaps (missing schema and 404 error) rather than content bullshit. Information density and semantic coherence are nearly perfect, as the site prioritizes regulatory disclosure over marketing persuasion.”
Analysis Disclosure & Source Attribution
Snapshot Date: May 29, 2026
Purpose: This data is presented under “Fair Use” / “Educational Exception” for the purpose of forensic semantic analysis, allowing users to see how machine logic interprets digital signals.
Machine Perception Notice: This evaluation is generated by machine-read logic (MRL). The AI interprets the “Digital Ghost” of a website (code, metadata, and semantic structures), which may differ from what a human sees at the same moment. This is an automated technical diagnostic and not a statement of fact or human opinion regarding the real-world integrity or legitimacy of the business. Any missing or inaccessible elements in the snapshot are treated as machine-read signals, reflecting AI rendering limitations rather than intentional omission.
Notice to the Evaluated Business: This analysis is part of a non-adversarial audit. The results are intended as professional feedback to help improve machine-readability and authority signals. Any company can use these insights for free. When content is updated, a fresh audit can be requested at any time to reflect the current state.
To All Users: You are encouraged to visit the live site at ABILIFY (aripiprazole) / Otsuka America Pharmaceutical, Inc. to view the most current version of their content and see directly what the company offers.